These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6546170)

  • 1. [Creatine phosphotransferase, B subunit, as a tumor marker. Preliminary results].
    Rubial A; Alvarez Moro FJ; Comet R; Bodi R; Lafuerza A; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):415-20. PubMed ID: 6546170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of radioimmunoassay of serum creatine kinase BB (CK-BB) as a tumor marker: studies in patients with various cancers and a comparison of CK-BB concentrations to prostate acid phosphatase concentrations.
    Zweig MH; Van Steirteghem AC
    J Natl Cancer Inst; 1981 May; 66(5):659-62. PubMed ID: 6939925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A macromolecule capable of modifying CK-MB results and of inducing false acute myocardial infarction diagnosis].
    de Almeida Camarozano AC; Gaspar Henriques LM
    Arq Bras Cardiol; 1996 Mar; 66(3):143-7. PubMed ID: 8762692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of osteopetrosis with an abnormal CK-MB/T-CK ratio].
    Ito K; Komiyama Y; Mitani K; Ogawa N; Egawa H; Takahashi H
    Rinsho Byori; 1997 Dec; 45(12):1197-200. PubMed ID: 9437904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Creatine kinase and its isoenzymes in breast tumor tissue].
    Pashintseva LP; Barlova MV; Bassalyk LS
    Eksp Onkol; 1986; 8(2):51-4. PubMed ID: 3698882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interference of CK-BB isoenzyme in the determination of CK-MB using the immunoinhibition method in patients with pulmonary diseases].
    Vrbica Z; Durović O; Oreb N
    Lijec Vjesn; 1997 Nov; 119(10):263-5. PubMed ID: 9531757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Creatine kinase and its isozymes].
    Takagi Y; Yasuhara T; Gomi K
    Rinsho Byori; 2001 Nov; Suppl 116():52-61. PubMed ID: 11797380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Creatine kinase (CK) activity and its isoenzyme MB in the serum of randomly selected patients without acute coronary disease].
    Mall T; Scholer A; Burckhardt D
    Schweiz Med Wochenschr; 1982 Jul; 112(29):1039-45. PubMed ID: 7112076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of serum creatine kinase MB in patients with cardiac damage after electric injuries].
    Zhang B; Yang Y; Tian Y; Li G; Zhang X; Li M; Hao Z
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):480-3. PubMed ID: 11825446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increase of creatine kinase mb isoenzyme out of a context of acute myocardial infarct].
    Fonseca JE; Calado L; Metrass MJ
    Acta Med Port; 1998 May; 11(5):507-10. PubMed ID: 9951062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum isoenzymes in cancer diagnosis and management.
    Mercer DW
    Immunol Ser; 1990; 53():613-29. PubMed ID: 2100575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of B subunit creatine kinase isoenzymes measured by a RIA method in patients with brain tumors and stroke. Preliminary results.
    Bonuccelli U; Nuti A; Del Chicca MG; Giraldi C; Boncompagni L; Clerico A
    Acta Neurol (Napoli); 1987 Jun; 9(3):169-77. PubMed ID: 3630788
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pregnancy-specific beta-1 glycoprotein (SP1) as a marker for tumors with or without trophoblastic character].
    Ruibal A; Comet R; Alvarez Moro FJ; Lafuerza A; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):427-34. PubMed ID: 6100801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum CK-BB. A biochemical marker in neonatal necrotizing enterocolitis].
    Samaniego Muñoz M; Sánchez Navarro MR
    An Esp Pediatr; 1996 Jun; 44(6):577-80. PubMed ID: 8849102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High creatine kinase MB concentration and activity in patients with rhabdomyosarcoma].
    Sawabe S; Hara K; Maekawa M
    Rinsho Byori; 1999 Nov; 47(11):1079-82. PubMed ID: 10590688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine kinase BB: a new tumor-associated marker.
    Silverman LM; Dermer GB; Zweig MH; Van Steirteghem AC; Tökés ZA
    Clin Chem; 1979 Aug; 25(8):1432-5. PubMed ID: 455680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
    Aleyassine H; MacIsaac SG
    Clin Biochem; 1980 Jun; 13(3):109-12. PubMed ID: 7418193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Macro creatine kinase: illness marker. Practical guide for the management].
    Ruiz Ginés MA; Calafell Mas MF; Ruiz Ginés JA; Fernández Rodríguez E
    An Med Interna; 2006 Jun; 23(6):272-5. PubMed ID: 17067219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The creatine kinase profile of a maintenance hemodialysis population: a possible marker of uremic myopathy.
    Cohen IM; Griffiths J; Stone RA; Leech T
    Clin Nephrol; 1980 May; 13(5):235-8. PubMed ID: 7398146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatine kinase BB and other markers of prostatic carcinoma.
    Silverman LM; Chapman JF; Jones ME; Dermer GB; Pullano T; Tökes ZA
    Prostate; 1981; 2(1):109-19. PubMed ID: 7024960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.